Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARγ-mediated mechanisms in Alzheimer's disease models
about
Unified theory of Alzheimer's disease (UTAD): implications for prevention and curative therapyRole of docosahexaenoic acid in the modulation of glial cells in Alzheimer's diseasePPARγ and the Innate Immune System Mediate the Resolution of InflammationMechanisms of omega-3 polyunsaturated fatty acids in prostate cancer preventionIs there a molecular logic that sustains neuronal functional integrity and survival? Lipid signaling is necessary for neuroprotective neuronal transcriptional programsExperimental evidence of ω-3 polyunsaturated fatty acid modulation of inflammatory cytokines and bioactive lipid mediators: their potential role in inflammatory, neurodegenerative, and neoplastic diseasesBeta-Amyloid Precursor Protein (βAPP) Processing in Alzheimer's Disease (AD) and Age-Related Macular Degeneration (AMD)Neuroinflammation in Alzheimer's diseasePro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation1α,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-β phagocytosis and inflammation in Alzheimer's disease patientsHuman cerebrospinal fluid fatty acid levels differ between supernatant fluid and brain-derived nanoparticle fractions, and are altered in Alzheimer's diseaseUnesterified docosahexaenoic acid is protective in neuroinflammation.Neuroprotectin D1 induces neuronal survival and downregulation of amyloidogenic processing in Alzheimer's disease cellular models.Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases.Temporal profiling of gene networks associated with the late phase of long-term potentiation in vivo.Neuroprotectin/protectin D1: endogenous biosynthesis and actions on diabetic macrophages in promoting wound healing and innervation impaired by diabetes.Resolution of inflammation is altered in Alzheimer's diseaseInflammatory cytokine-associated depressionPPAR-γ agonist GW1929 but not antagonist GW9662 reduces TBBPA-induced neurotoxicity in primary neocortical cells.Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution.12/15-Lipoxygenase metabolites of arachidonic acid activate PPARγ: a possible neuroprotective effect in ischemic brainEffects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD studyImaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans.NPD1-mediated stereoselective regulation of BIRC3 expression through cREL is decisive for neural cell survival.NF-кB-regulated micro RNAs (miRNAs) in primary human brain cells.Alcohol, phospholipase A2-associated neuroinflammation, and ω3 docosahexaenoic acid protection.Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer's disease (AD) and in age-related macular degeneration (AMD)14S,21R-dihydroxy-docosahexaenoic acid treatment enhances mesenchymal stem cell amelioration of renal ischemia/reperfusion injury.microRNA-34a-Mediated Down-Regulation of the Microglial-Enriched Triggering Receptor and Phagocytosis-Sensor TREM2 in Age-Related Macular DegenerationStereocontrolled total synthesis of neuroprotectin D1 / protectin D1 and its aspirin-triggered stereoisomerAmyloid beta (Aβ) peptide modulators and other current treatment strategies for Alzheimer's disease (AD).Cystatin C Shifts APP Processing from Amyloid-β Production towards Non-Amyloidgenic Pathway in Brain Endothelial Cells.Metal-sulfate induced generation of ROS in human brain cells: detection using an isomeric mixture of 5- and 6-carboxy-2',7'-dichlorofluorescein diacetate (carboxy-DCFDA) as a cell permeant tracer.Applications of metabolomics for understanding the action of peroxisome proliferator-activated receptors (PPARs) in diabetes, obesity and cancerAssessment of DHA on reducing early preterm birth: the ADORE randomized controlled trial protocol.microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF)Studying micro RNA Function and Dysfunction in Alzheimer's DiseaseWide-ranging alterations in the brain fatty acid complement of subjects with late Alzheimer's disease as detected by GC-MSNF-κB-regulated, proinflammatory miRNAs in Alzheimer's disease.Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis
P2860
Q26382049-CDF4F3D9-D5F0-4D60-98D1-4524EC64D014Q26766462-071A164A-AFE3-4721-A0CF-0BE1E9F7CE5FQ26771755-6F4372E4-8975-43CB-8658-DFB7CE203A7DQ26830150-839911B5-FDF5-4582-9342-FC73EB58B764Q26996617-DA353D73-46B9-4C9F-BECF-34C13D2DD4C6Q27021694-F3018A85-ABE4-40F8-86A3-CA1D044CE2A2Q27021938-D7A62B5A-7512-4B20-9607-0CAE7D7BB3B5Q28259238-4FF3884F-8CC2-4177-B1D9-124497998D3FQ28716294-FF437932-DD58-4372-BFD3-9B28832CF3F7Q33691958-328EB72B-D939-4041-BD53-A8A3F3719040Q33793583-84C3706D-7EEB-42E3-B079-A6172929D9CEQ33798922-89B69C27-E8BC-4FE5-8BC1-D2CBA153AFB9Q33853865-B0C1AB39-B91B-4262-8E9F-C33DFF0A310DQ34027672-A55CAF39-7748-487C-A693-0A4BA996B18FQ34339730-460FABDA-4687-430A-8702-9AA8B314322FQ34627478-35B4CC3F-2FF3-4ABC-8068-22ACD9B45795Q34765889-214D0104-23DD-4799-BC0F-BF8D90B0E4AFQ34825010-B7C8BD97-17A7-4FC6-87B7-BD9FE65DD95DQ35019416-C91914AE-CCBE-473F-8398-7A64DF3B6D5AQ35098090-3A28A5E7-B7FE-4D03-BC9A-A2FC698105E9Q35120876-3F44451D-2CDA-4216-92F5-0EE7BBC1F594Q35120950-E3BAD725-FC63-4420-A913-18078F176DB4Q35742545-1343C6DC-97B7-4527-8D4A-354AEB97E8D2Q35829878-A1122438-8A8E-4839-9007-C32693A6EBD4Q35874830-6C2743E3-9DAA-488F-921B-F24C64584907Q35879838-3A3D60B7-055C-455E-A893-D00F1F15413EQ35887465-449FE464-0E12-4C7E-B7A3-27DD4B74A618Q35895293-A0EA97E7-F537-44D8-BA5C-418C3FCBA4DDQ35947548-0B5A5693-2E39-4D8C-85B4-8997948589A3Q36018475-0FC9E68B-D158-49B6-A456-0F5890367243Q36103515-AE1F595A-7843-4369-B6CF-D22ECA917B1DQ36105690-05F1FEAA-D2AB-4AFF-BA87-6DD27B51E68DQ36202274-29D78A2B-BB52-4F69-A250-2FCE44EBBA5DQ36245143-B1194727-CFCF-4C4E-B883-CA0F8445F7B0Q36279075-D4DC8311-9B03-4731-AC67-F5D45847CDA6Q36499038-C156FD2B-D6AF-4E64-8939-C79FE6AB1433Q36589571-B234E595-72D3-4B54-8815-7EB2D7B4B901Q36595126-DAA06BF1-BEB4-4E58-B3EC-FD2D505616C3Q36632979-83760A41-A9B4-4C9F-B109-790860D8A45CQ36777563-5F2C23AD-6418-467E-A375-C74AB333A210
P2860
Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARγ-mediated mechanisms in Alzheimer's disease models
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Docosahexaenoic acid-derived n ...... in Alzheimer's disease models
@ast
Docosahexaenoic acid-derived n ...... in Alzheimer's disease models
@en
Docosahexaenoic acid-derived n ...... in Alzheimer's disease models
@en-gb
Docosahexaenoic acid-derived n ...... in Alzheimer's disease models
@nl
type
label
Docosahexaenoic acid-derived n ...... in Alzheimer's disease models
@ast
Docosahexaenoic acid-derived n ...... in Alzheimer's disease models
@en
Docosahexaenoic acid-derived n ...... in Alzheimer's disease models
@en-gb
Docosahexaenoic acid-derived n ...... in Alzheimer's disease models
@nl
altLabel
Docosahexaenoic Acid-Derived N ...... in Alzheimer's Disease Models
@en
prefLabel
Docosahexaenoic acid-derived n ...... in Alzheimer's disease models
@ast
Docosahexaenoic acid-derived n ...... in Alzheimer's disease models
@en
Docosahexaenoic acid-derived n ...... in Alzheimer's disease models
@en-gb
Docosahexaenoic acid-derived n ...... in Alzheimer's disease models
@nl
P2093
P2860
P3181
P1433
P1476
Docosahexaenoic acid-derived n ...... in Alzheimer's disease models
@en
P2093
Carl Julien
Frederic Calon
Jeremy W Winkler
Nicolas G Bazan
Walter J Lukiw
Yuhai Zhao
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0015816
P407
P577
2011-01-01T00:00:00Z